These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 22105921)

  • 1. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
    López-Hernández FJ; López-Novoa JM
    Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis.
    Mezzano S; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Carvajal G; Ruiz-Ortega M; Egido J
    Nephrol Dial Transplant; 2007 Jul; 22(7):1882-90. PubMed ID: 17403698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
    Lee HS; Song CY
    Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats.
    Ding G; Franki N; Kapasi AA; Reddy K; Gibbons N; Singhal PC
    Exp Mol Pathol; 2001 Feb; 70(1):43-53. PubMed ID: 11170790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in epithelial-mesenchymal transition: a new insight into obstructive nephropathy.
    Bani-Hani AH; Campbell MT; Meldrum DR; Meldrum KK
    J Urol; 2008 Aug; 180(2):461-8. PubMed ID: 18550128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential role of mesangial cells and podocytes in TGF-beta-induced mesangial matrix synthesis in chronic glomerular disease.
    Lee HS; Song CY
    Histol Histopathol; 2009 Jul; 24(7):901-8. PubMed ID: 19475536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tubulointerstitial inflammation in the progression of chronic renal failure.
    Rodríguez-Iturbe B; García García G
    Nephron Clin Pract; 2010; 116(2):c81-8. PubMed ID: 20502043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease.
    García-Sánchez O; López-Hernández FJ; López-Novoa JM
    Kidney Int; 2010 Jun; 77(11):950-5. PubMed ID: 20336053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological changes and immunohistochemical markers in the assessment of glomerulosclerosis in patients with glomerulonephritis.
    Bob FR; Gluhovschi G; Herman D; Bozdog G; Gluhovschi C; Velciov S; Potencz E; Petrica L
    Rom J Morphol Embryol; 2011; 52(3 Suppl):1027-32. PubMed ID: 22119820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells.
    Zeisberg M; Maeshima Y; Mosterman B; Kalluri R
    Am J Pathol; 2002 Jun; 160(6):2001-8. PubMed ID: 12057905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cellular and signalling alterations conducted by TGF-β contributing to renal fibrosis.
    Vega G; Alarcón S; San Martín R
    Cytokine; 2016 Dec; 88():115-125. PubMed ID: 27599257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
    Wang SN; Hirschberg R
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.
    Kopp JB; Factor VM; Mozes M; Nagy P; Sanderson N; Böttinger EP; Klotman PE; Thorgeirsson SS
    Lab Invest; 1996 Jun; 74(6):991-1003. PubMed ID: 8667617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy.
    Ina K; Kitamura H; Tatsukawa S; Takayama T; Fujikura Y; Shimada T
    Med Electron Microsc; 2002 Jun; 35(2):87-95. PubMed ID: 12181650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression in chronic kidney disease.
    Eddy AA
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):353-65. PubMed ID: 16198274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology.
    Bruijn JA; Roos A; de Geus B; de Heer E
    J Lab Clin Med; 1994 Jan; 123(1):34-47. PubMed ID: 8288959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I; Krzymański M
    Przegl Lek; 1996; 53(5):443-53. PubMed ID: 8754411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of tubular phenotypic changes on the development of diffuse interstitial fibrosis in renal allografts.
    Özdemir BH; Özdemir AA; Colak T; Sezer S; Haberal M
    Transplant Proc; 2011 Mar; 43(2):527-9. PubMed ID: 21440751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.